🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Our customers choose BioAscent to cost-effectively and securely manage their compounds, connect their CRO network, and accelerate their design-make-test cycles. Discover more about our compound management expertise: bit.ly/3qKVEjR #CompoundManagement #DrugDiscovery

We understand the importance of making the right compound, not any compound, and that delivering a successful molecule with the appropriate biological, ADME and safety profile is set at the design stage. Learn more: bit.ly/4hccuAv #MedChem #AssayDevelopment

Bio-Europe begins next week in Stockholm. Business Development Director for Europe Michalina Lewicka‑Yammine will be attending the event. To arrange a meeting, email [email protected]. Find out more: bit.ly/40iTNVN EBD Group #BIOEurope #IntegratedDrugDiscovery

Our state-of-the-art facility securely stores and manages customer libraries varying in size from tens of compounds, through to hundreds-of-thousands of compounds, in liquid and solid formats. Find out more: bit.ly/3qKVEjR #CompoundManagement #CompoundStorage

Today, we're showing appreciation to our brilliant team with some special spooky-themed goody bags. Each treat is a small token of gratitude for their hard work and commitment. Wishing everyone a happy Halloween. #TeamAppreciation #EmployeeRecognition #IntegratedDrugDiscovery

BioAscent's Business Development Director for Europe Michalina Lewicka-Yammine had the pleasure of attending the EBD Group Bio-Europe reception last night ahead of the main event. Find out more: bit.ly/40iTNVN #BIOEurope #Event #Networking #IntegratedDrugDiscovery

BIO-Europe is underway in Stockholm, Sweden. Business Development Director for Europe Michalina Lewicka-Yammine is attending and is available to answer questions about our services. To arrange a meeting, get in touch: [email protected]. Find out more: bioascent.com/news-events/ev…

The @ELRIG_UK Protein Sciences in Drug Discovery meeting begins next week. If you would like to arrange a meeting, please get in touch by emailing [email protected]. Find out more about the meeting: bioascent.com/news-events/ev… #ProteinScience2024 #IntegratedDrugDiscovery

Our computational chemists have years of knowledge and success applying multiple in silico ligand-based and structure-based methodologies at all stages of the drug discovery workflow. Find out more: bit.ly/372bPC7 #CompChem #LigandModelling #ComputationalChemistry

Senior BioAscent scientists, Duncan McArthur and Angelo Pugliese, named as authors on recent paper: ‘Reversible small molecule pan-Ras inhibitors display tunable affinity for the active and inactive forms of Ras’. Read the paper here: bit.ly/4fwa7Hv #DrugDiscovery

The @ELRIG_UK Protein Sciences in Drug Discovery meeting is underway at Hinxton Hall Conference Centre, Cambridgeshire. If you would like to arrange a meeting with David, please get in touch: [email protected]. Find out more: bit.ly/3ZacwBL #ProteinScience2024

Our customers choose BioAscent to cost-effectively and securely manage their compounds, connect their CRO network, and accelerate their design-make-test cycles. Find out more: bit.ly/3qKVEjR #DrugDiscovery #CompoundManagement

GPCR Drug Discovery at BioAscent - mailchi.mp/892b35a67887/p…

Simplify your compound management with Compound Connect - mailchi.mp/28268b4db887/c…